Skip to main content

Table 2 Treatment outcome after trimodal therapy

From: Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis

Univariate analysis

MST (months)

5-year survival (%)

P

Resection status

   

  R0

33

37.6

0.54

  R1

31

43.5

Histology

   

  Squamous cell

43

42.5

0.20

  Adenocarcinoma

21

36.0

Chemotherapy

   

  Induction

36

38.7

0.87

  Adjuvant

32

38.7

Type of surgery

   

  Lobectomy

43

51.9

0.054

  Bi-lobe/Pneumonectomy

22

19.5

 
  1. Univariate analysis.